Sigilon Therapeutics (SGTX) EBITDA (2020 - 2023)
Sigilon Therapeutics (SGTX) EBITDA from Dec 31, 2020 to Jun 30, 2023. The TTM Sigilon Therapeutics (SGTX) EBITDA is -$30M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Sigilon Therapeutics (SGTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.80% |
| All Time TTM | -45.74% |
Annual EBITDA change of Sigilon Therapeutics (SGTX)
| Year | EBITDA | Change |
|---|---|---|
| 2023 | -$14M | -66.86% |
| 2022 | -$42M | -43.10% |
| 2021 | -$75M | +43.89% |
| 2020 | -$52M | N/A |